SAN FRANCISCO, Dec. 26, 2024 /PRNewswire/ -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies to achieve a functional cure for chronic...
Hence then, the article about ausperbio secures 73 million in series b financing to advance functional cure for chronic hepatitis b was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( AusperBio Secures $73 Million in Series B Financing to Advance Functional Cure for Chronic Hepatitis B )
Also on site :
- Country Star Left Bleeding After Getting Struck in Face by Fan’s Phone
- ‘My mother was tricked by a fraudster pretending to be David Attenborough and gave them half of her life savings’
- Two weeks of war: Inside Trump’s risky decision to attack Iran — and the scramble to contain the fallout